文献速递青光眼

美国国立卫生研究院All of Us研究项目中青光眼患者药物依从性费用相关障碍的种族和民族差异

Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

这项横断面研究纳入美国国立卫生研究院All of Us研究项目中3826例青光眼患者,评估不同种族和民族在药物依从性费用相关障碍上的差异。调整混杂因素后,非西班牙裔非裔美国人和西班牙裔个体报告无法负担药物的比值比均高于非西班牙裔白人。作者建议临床医生主动发起关于费用的讨论以促进药物依从性和健康公平。

要点

  • 非西班牙裔非裔美国人无法负担药物的OR为1.82(95%CI 1.34-2.44),高于非西班牙裔白人。
  • 西班牙裔无法负担药物的OR为1.77(95%CI 1.25-2.49),高于非西班牙裔白人。
  • 非西班牙裔白人尽管报告费用困难的比例最低,但向临床医生要求低价药物的可能性与少数种族和民族群体相同。

核心结论

  • 非西班牙裔非裔美国人和西班牙裔个体自述无法负担药物的比值比显著高于非西班牙裔白人。
  • 作者建议临床医生主动发起关于费用的讨论,以促进药物依从性和健康公平。

研究设计与样本

  • 横断面研究,纳入美国国立卫生研究院All of Us研究项目中根据电子健康记录诊断代码诊断为青光眼、参与Health Care Access and Utilization调查且所有协变量数据完整的患者。
  • 共纳入3826例青光眼患者,其中非裔美国人481例(12.6%)、非西班牙裔亚裔119例(3.1%)、西班牙裔351例(9.2%)、非西班牙裔白人2875例(75.1%)。
  • 数据收集时间为2016年6月至2021年3月,数据分析时间为2021年8月至2021年11月。
  • 采用逻辑回归评估费用相关障碍与种族和民族之间的关联,多变量模型调整年龄、性别、医疗保险状态、教育和收入。

主要发现

  • 中位(IQR)年龄为69(60-75)岁,女性2307例(60.3%)。
  • 调整混杂因素后,非西班牙裔非裔美国人(OR 1.82;95%CI 1.34-2.44)和西班牙裔(OR 1.77;95%CI 1.25-2.49)比非西班牙裔白人更可能报告无法负担药物。
  • 非西班牙裔白人报告费用困难的比例最低,但其向临床医生要求低价药物的可能性与少数种族和民族群体相同。

关键数值与推荐

  • 费用相关障碍包括:无法负担处方药、为省钱而漏服药物、为省钱而减少用药、为省钱而延迟取药、为省钱而要求低价药物、为省钱而从其他国家购买处方药、为省钱而使用替代疗法。
  • 以非西班牙裔白人为参照组,非西班牙裔非裔美国人无法负担药物的OR为1.82(95%CI 1.34-2.44),西班牙裔为1.77(95%CI 1.25-2.49)。

临床怎么用

  • 作者建议临床医生应主动发起关于费用的讨论,以促进药物依从性和健康公平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Ability to afford medication is a major determinate of medication adherence among patients. OBJECTIVE: To determine cost-related barriers to medication adherence by race and ethnicity in a nationwide cohort of patients with glaucoma. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included patients with glaucoma enrolled in the National Institutes of Health All of Us Research Program, a nationwide longitudinal cohort of US adults, with more than 300 000 currently enrolled. Individuals with a diagnosis of glaucoma based on electronic health record diagnosis codes who participated in the Health Care Access and Utilization survey and had complete data on all covariates were studied. Data were collected from June 2016 to March 2021, and data were analyzed from August to November 2021. EXPOSURES: Race and ethnicity defined as non-Hispanic African American, non-Hispanic Asian, Hispanic, and non-Hispanic White. MAIN OUTCOMES AND MEASURES: Logistic regression was used to evaluate the association between reported cost-related barriers to medication adherence (could not afford prescription medication, skipped medication doses to save money, took less medication to save money, delayed filling a prescription to save money, asked for lower-cost medication to save money, bought prescriptions from another country to save money, and used alternative therapies to save money) and race and ethnicity, adjusting multivariable models by age, gender, health insurance status, education, and income. Odds ratios of these barriers were obtained by race and ethnicity, with non-Hispanic White race as the reference group. RESULTS: Of 3826 included patients with glaucoma, 481 (12.6%) were African American, 119 (3.1%) were non-Hispanic Asian, 351 (9.2%) were Hispanic, and 2875 (75.1%) were non-Hispanic White. The median (IQR) age was 69 (60-75) years, and 2307 (60.3%) were female. After adjusting for confounders, non-Hispanic African American individuals (odds ratio, 1.82; 95% CI, 1.34-2.44) and Hispanic individuals (odds ratio, 1.77; 95% CI, 1.25-2.49) were more likely than non-Hispanic White individuals to report not being able to afford medications. Further, despite having the lowest rate of endorsing difficulty affording medications, non-Hispanic White individuals were equally likely to ask for lower-cost medication from their clinicians as individuals of racial and ethnic minority groups. CONCLUSIONS AND RELEVANCE: In this study, there was significantly higher odds of self-reported difficulty affording medications among non-Hispanic African American and Hispanic individuals compared with non-Hispanic White individuals. Clinicians should be proactive and initiate discussions about costs in an effort to promote medication adherence and health equity among patients.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Delavar A, Radha Saseendrakumar B, Weinreb RN, et al. Racial and Ethnic Disparities in Cost-Related Barriers to Medication Adherence Among Patients With Glaucoma Enrolled in the National Institutes of Health All of Us Research Program. JAMA Ophthalmol. 2022. PMID: 35238904. doi:10.1001/jamaophthalmol.2022.0055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。